US · Healthcare

Global Health Clinics Ltd (LRSNF)

Drug Manufacturers - Specialty & Generic

Global Health Clinics Ltd (LRSNF) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for LRSNF

P/E ratio

18.00

Global Health Clinics Ltd (LRSNF) — FAQ

What is LRSNF's P/E ratio?

The price-to-earnings (P/E) ratio for Global Health Clinics Ltd (LRSNF) is 18.00 (data as of 2026-05-23).

Does Global Health Clinics Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Global Health Clinics Ltd (LRSNF). Check the MyAverix Finance app for the latest dividend data.

What sector is Global Health Clinics Ltd in?

Global Health Clinics Ltd (LRSNF) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is LRSNF listed on?

LRSNF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)